We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: news

Safety of Biopsy in Pheochromocytoma and Paraganglioma: What a Global Study Found

MedXY Editorial Team•May 15, 2026•news
biopsy safetycatecholamine complicationsParagangliomaPheochromocytomaretrospective cohort study

Safety of Biopsy in Phaeochromocytoma and Paraganglioma

Phaeochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors that can produce excess catecholamines such as adrenaline and noradrenaline. Because these hormones can trigger severe blood pressure spikes, dangerous heart rhythms, or other complications, biopsy has traditionally been discouraged when PPGL is suspected. This international multicentre study re-examined that long-standing caution by looking at real-world biopsy outcomes across multiple hospitals and countries.

Why biopsy has been controversial

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Octreotide in the Management of Catecholamine-Secreting Pheochromocytomas and Paragangliomas: A Promising Adjunctive TherapyOctreotide shows potential as an effective adjunctive therapy in catecholamine-secreting pheochromocytomas and paragangliomas, improving biochemical, hemodynamic, and metabolic parameters and supporting perioperative management.Aug 22, 2026Increased Risk of Pseudophakic Cystoid Macular Edema After Cataract Surgery in Eyes with Prior Pars Plana Vitrectomy: Insights from a Large Retrospective Cohort StudyThis study reveals that eyes with previous pars plana vitrectomy exhibit a significantly higher risk of cystoid macular edema following cataract surgery, underscoring the need for careful postoperative monitoring and potential prophylaxis sAug 4, 2026Most Bilateral Adrenal Lesions Are Benign and Concordant, but Asynchronous Presentation Signals Higher Malignancy RiskA large retrospective cohort shows that bilateral adrenal masses are usually benign and concordant, but asynchronous or discordant lesions identify a clinically important subgroup enriched for malignancy and pheochromocytoma.May 13, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Preemptive Magnesium Sulfate Infusion Significantly Stabilizes Hemodynamics During Pheochromocytoma ResectionA randomized, double-blind trial confirms that preemptive magnesium sulfate reduces intraoperative hemodynamic instability by nearly 50% in patients undergoing pheochromocytoma and paraganglioma resection, providing a safe and effective adjJan 19, 2026
Targeting Tumor Hypoxia Pathways: Belzutifan’s Promise in Advanced Paraganglioma and Pheochromocytoma TreatmentThis article reviews a phase 2 trial of belzutifan, a HIF-2α inhibitor, demonstrating durable antitumor activity and manageable safety in advanced pheochromocytoma and paraganglioma, highlighting its potential as a targeted therapy.Oct 24, 2025